Deccan Health CareBOM:542248 -1.97%81 Operating Margin % is 2.43% as of Mar. 2026, which is 72% below its 10-year median of 8.53. GuruFocus rates BOM:542248 with a GF Score™ of 81/100 and a GF Value™ of ₹26.20 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 956 Drug Manufacturers companies, Deccan Health Care ranks worse than 59% on this metric.
Deccan Health Care (BOM:542248) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Deccan Health Care Operating Margin % Related Terms
Deccan Health Care Operating Margin % Historical Data
* Premium members only.
The historical data trend for Deccan Health Care's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:542248 vs ZTS, UTHR: Operating Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Deccan Health Care's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Deccan Health Care Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Deccan Health Care's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Deccan Health Care's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Deccan Health Care's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Deccan Health Care (BOM:542248) has a Operating Margin % of 2.43% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Deccan Health Care and its competitors. This is 72% below median its historical median of 8.53. Over the past decade, Deccan Health Care's Operating Margin % has ranged from 1.33 to 39.59. According to the industry distribution chart, Deccan Health Care ranks #564 out of 956 companies in the Drug Manufacturers industry, placing it in the top 59%.
Is Deccan Health Care's Operating Margin % too high?
Deccan Health Care's current Operating Margin % of 2.43% is 72% below median its 10-year median of 8.53. Over the past 10 years, this metric has ranged from a low of 1.33 to a high of 39.59. The Drug Manufacturers industry median Operating Margin % is 7.58. Deccan Health Care's value of 2.43% is 67.9% below this industry median. Based on the distribution chart, Deccan Health Care ranks #564 out of 956 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Deccan Health Care has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Deccan Health Care's Operating Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Deccan Health Care ranks #564 out of 956 companies for Operating Margin %. This places Deccan Health Care in the lower half of its industry. The industry median Operating Margin % is 7.58. Deccan Health Care's value of 2.43% is 67.9% below this benchmark. Historically, Deccan Health Care's own Operating Margin % has ranged from 1.33 to 39.59 over the past decade. While the company's 10-year median is 8.53 vs. the industry median of 7.58, Deccan Health Care has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.58, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Deccan Health Care's current Operating Margin % of 2.43% is 67.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Deccan Health Care and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Deccan Health Care's current Operating Margin % is 2.43%, which is 72% below median its own 10-year median of 8.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Deccan Health Care stock overvalued right now?
Based on GuruFocus' analysis, Deccan Health Care (BOM:542248) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹26.20, compared to a current price of ₹13.43 — trading 48.7% below its estimated fair value. The current Operating Margin % is 2.43%, which is 72% below median its 10-year median of 8.53 and 67.9% below the Drug Manufacturers industry median of 7.58. Deccan Health Care's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Deccan Health Care (BOM:542248), the current Operating Margin % is 2.43% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Deccan Health Care (BOM:542248) Overvalued in 2026?
Based on GuruFocus' analysis, Deccan Health Care stock appears to be undervalued.
The current stock price of ₹13.43 is trading 48.7% below its estimated GF Value™ of ₹26.20.
GuruFocus considers Deccan Health Care to be Significantly Undervalued.
Key valuation signals for BOM:542248:
Operating Margin %: 2.43% (72% below median its 10-year median of 8.53)
GF Value™: ₹26.20 vs. price of ₹13.43 (48.7% below fair value)
Industry Position: 67.9% below the Drug Manufacturers median (#564 of 956)
No single metric tells the full story. See the BOM:542248 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Deccan Health Care Ltd is into developing, manufacturing, and marketing a broad range of healthcare products, including nutraceutical, cosmeceutical, and ayurveda products (Fast Moving Consumer Health Products). Its products are Nutraceutical Food Products and other supplements and medicines. The company is operating in a single segment of manufacturing of nutraceutical products. The company operates in India as well as exports its products to other countries, and the majority of its revenue comes from India.
81GF Score
Get the complete analysis for BOM:542248
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542248 has been successfully added to your 
